Enter assignee name

EPO Patents = 2

Forward Citations = 0

Loading Chart...

6 inventors (with patents filed for the assignee):

Mark J Cantwell (5 out of 13 patents)

Patrick Hwu (2 out of 13 patents)

Willem Overwijk (2 out of 4 patents)

4. Amer A Beg (2 out of 3 patents)

5. Manisha Singh (2 out of 2 patents)

6. Scott Antonia (1 out of 8 patents)

7. Charles E Prussak (12 patents)

8. Willem W Overwijk (0 patent)

5 patents: Sort by Forward Citations

1. 12239666 - Oncolytic virus or antigen presenting cell mediated cancer therapy using type I interferon and CD40-ligand (2025-03-04),

2. 12171803 - Methods of CD40 and toll like receptor immune activation (2024-12-24),

3. 11951141 - Replication-enhanced oncolytic adenoviruses (2024-04-09),

4. 11594135 - Methods of CD40 activation and immune checkpoint blockade (2023-02-28),

5. 11298420 - Armed oncolytic viruses (2022-04-12),

Memgen, Inc. is an innovative biotechnology company focused on developing novel therapeutic solutions through advanced genetic engineering and synthetic biology. The firm's mission is to harness the power of memory-enhancing biological mechanisms to address cognitive decline and other neurological disorders. With a robust pipeline of cutting-edge therapies and a commitment to scientific excellence, Memgen aims to improve the quality of life for individuals suffering from memory-related conditions. The company's team comprises experts in molecular biology, neuroscience, and biopharmaceutical development, all dedicated to translating breakthrough research into real-world applications. Memgen is poised to lead the field of cognitive health with its transformative approaches.

Profile summary based on public USPTO records.